Just hoping like I have for a long time now about the name change. Still very happy over the progress the company has made regarding products and the rollout of those products. This has an OWC* look. If this can just run to $3 a share like OWC* did, we will all be doing rather well.
Go RSII! Keep up the good work. Not expecting a lot from the financials as the products are not rolled out yet to make a difference in the revenue department. This IMO will take time. This still does not mean that DiPrima doesn't need to be woken up. He is the CFO and is responsible for things such as THIS (the name change). At least by what others have said they have submitted the name change to FINRA so it is in FINRA's hands. Only issue there is FINRA is very short handed and tend to take a little more time than what would be considered acceptable. They need to hire a few more people so they can get the job done expediently.
In a couple more years I can see this being a dollar company. It will need some suprising financials to get there though IMO.
Short term with the rollout of the peptide cream in late April or early May I can see the excitement taking this to at least a nickel. ("We could not be more excited to announce that after a recent meeting with the manufacturer of our clinical strength peptide serum, we are officially entering production phase for the product line and it will be on sale, available for national distribution, in late April/early May," states Hall. "This means revenues, revenues and more revenues.")
We really need to lock the float here folks as there is no reason IMO for anyone to sell this basement priced stock below a nickel.
Go RSII!
News 
Market Data 
Discover 
